Big Pharma Giant Kicks Off Q3 Earnings After Hiking Prices More Than 40 Times This Year

This week, brand name drug giant Johnson & Johnson kicked off the first round of Big Pharma earnings calls for the third quarter of 2023. The company surpassed Wall Street analysts’ earnings and profit expectations after having hiked prices more than 40 times just so far this year.

Johnson & Johnson

The strong earnings report comes as the Big Pharma giant has continued to price-gouge patients, with more than 30 price hikes in each of the last two years. Johnson & Johnson also has a history of engaging anti-competitive practices to block its blockbuster products from facing competition.

Johnson & Johnson

Stay tuned as we continue to monitor third quarter earnings calls from brand name drug companies in the weeks ahead.

Learn more about solutions to lower prescription drug prices and hold Big Pharma accountable HERE.

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.